急性心肌梗死心肺复苏后溶栓治疗临床价值探讨

Clinical evaluation of thrombolytic therapy after cardiopulmonary resuscitation in patients with acute myocardial infarction

目的:探讨急性心肌梗死心肺复苏后溶栓治疗的安全性及临床价值。方法:选择7例急性心肌梗死并心肺复苏后溶栓治疗的患者,分析其冠脉再通率、自主循环恢复率、急性期死亡率、出院生存率、重要脏器出血的发生率、脑复苏的成功率等。结果:对于急性心肌梗死并心肺复苏后的患者,在排除急性心包填塞、胸腹腔出血、继发性颅内出血后给予及时溶栓开通冠脉,能提高患者的自主循环恢复率、出院生存率、降低急性期死亡率,重要脏器出血的发生率无明显提高;对于发病年龄较轻、心肺复苏时间<10 min的患者,脑复苏的成功率较高。结论:急性心肌梗死心肺复苏后溶栓治疗是安全有效的。

Objective：To investigate the clinical value and security of thrombolytic therapy after cardiopulmonary resuscitation（CPR） in patients with acute myocardial infarction（AMI）.Method： Thrombolytic therapy was performed in 7 patients with AMI and CPR.The coronary artery recanalization,circulation recovery,vital organ bleeding,cerebral resuscitation,survival rate and mortality were analyzed.Result：After excluding cardic tamponade and acute internal hemorrhage,the thrombolytic therapy performed in time increased the circulation recovery and survival rate and also can reduce mortality rate.While it did not increase the rate of vital organ bleeding.The success rate for cerebral resuscitation was higher in those!young patients with less than 10 minutes for CRP.Conclusion：Thrombolytic therapy in curing the patients with AMI and CPR is safe and effective.